•
Nigeria-based pharmaceutical manufacturer Fidson Healthcare Plc has entered into a strategic partnership with Jiansu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund to establish a state-of-the-art drug manufacturing facility in the Lekki free trade zone near Lagos, Nigeria. This joint venture aims to enhance local production capabilities, particularly for…
•
China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) has reportedly entered into a strategic cooperation agreement with Nigeria-based Fidson Healthcare plc. The partnership aims to facilitate the import of innovative HIV/AIDS therapies into Nigeria, a country with a significant population of 1.9 million HIV-infected individuals. Multi-Layered Collaboration on HIV/AIDS TreatmentsThe…